The authors call it "an in-office linguistic study" and write that it "was conducted to assess physician - "patient discussions of mixed dyslipidemia." But it's really an Abbott marketing study for Niaspan, the company's long-acting niacin product, and the question is: why is it published in the American Journal of Cardiology ? The study involves ...